RajSatyanarayanaMD

PubMed

• 92 citations
  Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis
  Patrick S.C. Leung, Lorenzo Rossaro, Paul A. Davis, Ogyi Park, Atsushi Tanaka
  Hepatology. 2007-11-01
• 240 citations
  Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study
  Adrian Reuben, Holly Tillman, Robert J. Fontana, Timothy Davern, Brendan M. McGuire
  Annals of Internal Medicine. 2016-06-07
• 88 citations
  The Natural History of Severe Acute Liver Injury
  David G. Koch, Jaime L. Speiser, Valerie Durkalski, Robert J. Fontana, Timothy Davern
  The American Journal of Gastroenterology. 2017-09-01

Journal Articles

• Plasma osteopontin in acute liver failure  
  Srungaram P, Rule JA, Yuan HJ, Reimold A, Dahl B, Sanders C, Lee WM, Larson AM, Liou I, Davern T, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh AO, Blei A,..., Cytokine, 1/1/2015
• Micro-RNA-122 levels in acute liver failure and chronic hepatitis C  
  Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM, Larson AM, Liou I, Davern T, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Obaid A, Shaikh S, Blei A, Gang..., J Med Virol, 1/1/2014
• Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis  
  Leung PSC, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, Miyakawa H, Norman GL, Lee W, Gershwin ME, Lee WM, Polson J, Pezzia C, Larson A, Davern T, Martin P, McCas..., Hepatology, 1/1/2007
• Alpha-fetoprotein and prognosis in acute liver failure  
  Schiodt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM, Liver Transpl, 1/1/2006
• Join now to see all

Books/Book Chapters

• The Washington Manual of Medical Therapeutics 
  Chapter: Liver disease. 
  Satyanarayana R, Lisker-Melman MEdition 30th,

Abstracts/Posters

• Sustained virological response results of telaprevir-based triple antiviral treatment for recurrent hcv genotype 1 after liver transplantation: a single center uniform...
  Pungpapong S, Murphy JL, Henry TM, Ryland K, Yataco ML, Satyanarayana R, Rosser B, Keaveny A, Hepatology, 1/1/2013
• First report of experience using telaprevir with peginterferon and ribavirin to treat recurrent hepatitis c genotype 1 in recipients of liver and kidney transplantation.
  Pungpapong S, Satyanarayana R, Rosser B, Yataco M, Mai M, Wadei H, Gonwa T, Keaveny A, Am J Transplant, 1/1/2013
• Preliminary experience using telaprevir with peginterferon and ribavirin for treatment of HCV genotype 1 after liver transplantation.
  Pungpapong S, Murphy JL, Henry TM, Ryland K, Satyanarayana R, Rosser B, Yataco ML, Keaveny A, Hepatology, 1/1/2012
• Initial experience utilizing telaprevir with peginterferon and ribavirin for treatment of hepatitis C genotype 1 after liver transplantation.
  Pungpapong S, Murphy J, Henry T, Satyanarayana R, Rosser B, Yataco M, Harnois D, Patel T, Keaveny A, Am J Transplant, 1/1/2012
• Outcome of liver transplant recipients with membranoproliferative glomerulonephritis (MPGN) on pre-transplant kidney biopsy.
  Wadei HM, Nur L, Gonwa TA, Rosser BG, Satyanarayana R, Mai M, Sibulesky L, Keaveny A, Am J Transplant, 1/1/2011
• Liver transplantation for hepatocellular carcinoma within and beyond milan criteria: microvascular invasion holds the key.
  Nguyen JH, Harnois DM, Rosser B, Pungpapong S, Satyanarayana R, Willingham DL, Aranda-Michel J, Taner B, Krishna M, Keaveny AP, Nakhleh RE, Hepatology, 1/1/2010
• Improving outcomes in liver transplantation for HCV and non HCV recipients.
  Dickson RC, Pungpapong S, Taner B, Keaveny AP, Ghabril M, Aranda-Michel J, Satyanarayana R, Bonatti H, Rosser B, Harnois DM, Nguyen JH, Hepatology, 1/1/2009
• Consensus interferon therapy for hepatitis C recurrence after pegylated intereferon failure post liver transplant.
  Ghabril M, Dickson RC, Lucas J, Aranda-Michel J, Keaveny A, Rosser B, Harnois DM, Bonatti H, Satyanarayana R, Hewitt WR, Nguyen JH, Hepatology, 1/1/2007
• Experience with 108 liver transplants from a single institution using donation after cardiac death donors.
  Grewal HP, Nguyen JH, Hewitt WR, Willingham DL, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois DM, Dickson RC, Steers JL, Kramer D, Hughes CB, Am J Transplant, 1/1/2007
• Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serum viral clearance.
  Ghabril M, Krishna M, Lloyd R, Keaveny A, Aranda-Michel J, Rosser B, Nguyen J, Harnois D, Satyanarayana R, Dickson RC, Am J Transplant, 1/1/2007
• Use of young donor grafts in adult liver transplantation for Hepatitis C.
  Ghabril M, Nguyen J, Shalev J, Aranda-Michel J, Keaveny A, Rosser B, Satyanarayana R, Harnois D, Kramer D, Hewitt W, Willingham D, Grewal H, Hughes C, Dickson R, Am J Transplant, 1/1/2007
• Outcome in patients undergoing cardiac interventions before and after liver transplantation.
  Herman M, Bonatti H, Aranda-Michel J, Dickson RC, Nguyen J, Satyanarayana R, Harnois D, Rosser B, Hewitt W, Hughes C, Yip D, Keaveny A, Am J Transplant, 1/1/2007
• A single center experience using donation after cardiac death donors over 60 years old.
  Grewal HP, Hewitt WR, Nguyen JH, Willingham DL, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois DM, Dickson RC, Steers JL, Kramer DJ, Hughes CB, Liver Transpl, 1/1/2007
• Predicting cardiovascular events after liver transplantation.
  erman M, Pungpapong S, Aranda-Michel J, Rosser B, Harnois DM, Dickson RC, Satyanarayana R, Yip D, Keaveny A, Hepatology, 1/1/2007
• Use of donation-after-cardiac-death (DCD) donors for combined liver and kidney transplantation.
  Hewitt WR, Stauffer J, Mai M, Grewal H, Arasi L, Rosser B, Kramer D, Canabal J, Nguyen JH, Wadei H, Ahsan N, Willingham D, Keaveny A, Aranda-Michel J, Harnois DM, Saty..., Hepatology, 1/1/2007
• Patient survival in fibrosis progression after liver retransplantation for hepatitis C infection.
  Ghabril M, Krishna M, Keaveny A, Aranda-Michel J, Rosser B, Harnois D, Satyanarayana R, Grewal H, Willingham D, Hewitt W, Nguyen J, Hughes C, Steers J, Dickson RC, Hepatology, 1/1/2005
• Liver retransplantation and hepatitis C infection.
  Ghabril M, Krishna M, Keaveny A, Aranda-Michel J, Rosser B, Harnois D, Satyanarayana R, Grewal H, Willingham D, Hewitt W, Nguyen J, Hughes C, Steers J, Dickson RC, Am J Transplant, 1/1/2005
• The effect of HBV core AB-positive donors on patients undergoing liver transplantation for end stage liver disease due to HCV infection.
  Yen RD, Krishna M, Pungpapong S, Ghabril M, Rosser B, Aranda-Michel J, Keaveny A, Satyanarayana R, Harnois D, Grewal H, Hewitt W, Willingham D, Hughes C, Steers J, Dic..., Am J Transplant, 1/1/2005
• Cardiovascular risk assessment and outcome after liver transplantation.
  Pungpapong S, Aranda-Michel J, Dickson RC, Yip D, Rosser B, Satyanarayana R, Harnois D, Keaveny A, Am J Transplant, 1/1/2005
• Effect of timing of interferon therapy on fibrosis progression in recurrent hepatitis C infection after liver transplantation.
  Ghabril MS, Krishna M, Machicao VI, Bonatti H, Borlaza RF, Rosser B, Satyanarayana R, Aranda-Michel J, Aqel B, Keaveny A, Harnois D, Hewitt W, Grewal H, Nguyen J, Hugh..., Am J Transplant, 1/1/2004
• Interleukin-2 receptor alpha sub-unit antibody (IL-2R alpha-A beta) therapy allows delayed introduction of calcineurin-inhibitor (CI) based immunosuppression in liver ...
  Rosser B, Mai M, Kramer D, Grewal H, Satyanarayana R, Keaveny A, Dickson R, Harnois D, Hewitt W, Nguyen J, Hughes C, Gonwa T, Steers J, Am J Transplant, 1/1/2004
• Liver tissue and serum viral load do not predict severity of recurrent hepatitis C after liver transplantation.
  Machicao VI, Mendez J, Krishna M, Bonatti H, Satyanarayana R, Rosser B, Aqel B, Harnois D, Steers JL, Dickson RC, Am J Transplant, 1/1/2003
• Patients transplanted for non alcoholic steatohepatitis have a higher prevalence of heterozygous alpha 1-antitrypsin phenotype.
  Tabesh A, Bonatti H, Machicao V, Harnoise D, Steers J, Satyanarayana R, Nguyen J, Dickson R, Am J Transplant, 1/1/2003
• Liver tissue and serum viral load do not predict severity of recurrent hepatitis C after liver transplantation.
  Machicao VI, Mendez J, Krishna M, Bonatti H, Satyanarayana R, Rosser B, Aqel B, Harnois D, Steers J, Dickson RC, American Journal of Transplantation, 1/1/2003
• Prevalence and natural history of GAVE in patients undergoing liver transplantation.
  Ward, E, Bonatti H, Machicao, V, Dickson, R, Harnois D, Rosser B, Satyanarayana R, Scolapio J, Raimondo M, Gastroenterology, 1/1/2003
• Join now to see all

Lectures

• "Coagulation in liver disease" 
  Mayo CLinic Florida, Jacksonville, FL - 1/1/2011
• How to trerat Hepatitis C in the liver transplant patient. 
  Scottsdale, AZ - 1/1/2008
• "Breese" 
  Panama City, FL - 1/1/2005
• "Fatty Liver Disease" 
  Orlando, FL - 1/1/2004
• "Quality of Life Post Liver Transplantation" 
  Amelia Island, FL - 1/1/2003
• "Support of Patients Prior to Liver Transplantation" 
  Jacksonville, FL - 1/1/2002
• "Hepatitis C: New Perspectives" 
  St. Louis, MO - 1/1/2001
• Hepatitis C: The primary care physician's perspective. 
  Kneibert Clinic, Poplar Bluff, MO - 1/1/2001
• Hepatitis C: A Primary Care Physician's Perspective. 
  St. Joseph's Hospital, Breese, IL - 1/1/2001
• Diet and Nutrition in Liver Disease. 
  St. Louis, MO - 1/1/2000
• Challenges in the Management of Hepatocellular Carcinoma. 
  MO - 1/1/2000
• Hepatic Granulomas. 
  MO - 1/1/2000
• Alcoholic Liver Disease. 
  Carbondale Clinic, Carbondale, IL - 1/1/2000
• Management of Variceal Bleeding. 
  MO - 1/1/1999
• "Variceal Bleeding" 
  1/1/1999
• Management of upper gastrointestinal bleeding in liver disease. 
  Pondicherry, India - 1/1/1999
• Malnutrition in Liver Disease. 
  Columbia, SC - 1/1/1998
• Protein Energy Malnutrition in Liver Disease. 
  San Antonio, TX - 1/1/1998
• Chemotherapeutic Agents and the Liver. 
  MO - 1/1/1996
• "Hepatitis G- Myth or Reality?" 
  MO - 1/1/1996
• Intestinal Lymphomas. 
  MO - 1/1/1995
• Join now to see all